Menu
Search icon
  1. Home Page
    2. ›
  2. Counties
    3. ›
  3. Idaho County
    4. ›
  4. 83530
    5. ›
  5. IRWIN DRUG, INC.

IRWIN DRUG, INC.

Company Details

Name: IRWIN DRUG, INC.
Jurisdiction: Idaho
Legal type: General Business Corporation (D)
Status: Active-Good Standing
Date of registration: 03 Nov 1965 (59 years ago)
Financial Date End: 30 Nov 2025
Date dissolved: 22 Feb 2025
Entity Number: 123189
Place of Formation: IDAHO
File Number: 123189
ZIP code: 83530
County: Idaho County
Mailing Address: 146 W MAIN ST GRANGEVILLE, ID 83530-1932

form 5500

Plan Name Plan Year EIN/PN Received Sponsor Total number of participants
IRWIN DRUG, INC. 401K PROFIT SHARING PLAN 2023 820263154 2024-11-12 IRWIN DRUG, INC. 37
File View Page
Three-digit plan number (PN) 001
Effective date of plan 1966-03-01
Business code 446110
Sponsor’s telephone number 2089831090
Plan sponsor’s address 146 W. MAIN STREET, GRANGEVILLE, ID, 835301932
IRWIN DRUG, INC. 401K PROFIT SHARING PLAN 2023 820263154 2024-10-14 IRWIN DRUG, INC. 41
File View Page
Three-digit plan number (PN) 001
Effective date of plan 1966-03-01
Business code 446110
Sponsor’s telephone number 2089831090
Plan sponsor’s address 146 W. MAIN STREET, GRANGEVILLE, ID, 835301932
IRWIN DRUG, INC. 401K PROFIT SHARING PLAN 2022 820263154 2024-11-12 IRWIN DRUG, INC. 41
File View Page
Three-digit plan number (PN) 001
Effective date of plan 1966-03-01
Business code 446110
Sponsor’s telephone number 2089831090
Plan sponsor’s address 146 W. MAIN STREET, GRANGEVILLE, ID, 835301932
IRWIN DRUG, INC. 401K PROFIT SHARING PLAN 2022 820263154 2023-10-13 IRWIN DRUG, INC. 13
File View Page
Three-digit plan number (PN) 001
Effective date of plan 1966-03-01
Business code 446110
Sponsor’s telephone number 2089831090
Plan sponsor’s address 146 W. MAIN STREET, GRANGEVILLE, ID, 835301932
IRWIN DRUG, INC. 401K PROFIT SHARING PLAN 2021 820263154 2022-10-14 IRWIN DRUG, INC. 13
File View Page
Three-digit plan number (PN) 001
Effective date of plan 1966-03-01
Business code 446110
Sponsor’s telephone number 2089831090
Plan sponsor’s address 146 W. MAIN STREET, GRANGEVILLE, ID, 835301932
IRWIN DRUG, INC. 401K PROFIT SHARING PLAN 2021 820263154 2024-11-12 IRWIN DRUG, INC. 38
File View Page
Three-digit plan number (PN) 001
Effective date of plan 1966-03-01
Business code 446110
Sponsor’s telephone number 2089831090
Plan sponsor’s address 146 W. MAIN STREET, GRANGEVILLE, ID, 835301932
IRWIN DRUG , INC. 401K PROFIT SHARING PLAN 2019 820263154 2020-10-06 IRWIN DRUG, INC. 44
File View Page
Three-digit plan number (PN) 001
Effective date of plan 1966-03-01
Business code 446110
Sponsor’s telephone number 2089831090
Plan sponsor’s address 146 W. MAIN STREET, GRANGEVILLE, ID, 835301932
IRWIN DRUG , INC. 401K PROFIT SHARING PLAN 2018 820263154 2019-10-09 IRWIN DRUG, INC. 43
File View Page
Three-digit plan number (PN) 001
Effective date of plan 1966-03-01
Business code 446110
Sponsor’s telephone number 2089831090
Plan sponsor’s address 146 W. MAIN STREET, GRANGEVILLE, ID, 835301932
IRWIN DRUG , INC. 401K PROFIT SHARING PLAN 2017 820263154 2018-10-15 IRWIN DRUG, INC. 44
File View Page
Three-digit plan number (PN) 001
Effective date of plan 1966-03-01
Business code 446110
Sponsor’s telephone number 2089831090
Plan sponsor’s address 146 W. MAIN STREET, GRANGEVILLE, ID, 835301932
IRWIN DRUG , INC. 401K PROFIT SHARING PLAN 2016 820263154 2017-10-12 IRWIN DRUG, INC. 38
File View Page
Three-digit plan number (PN) 001
Effective date of plan 1966-03-01
Business code 446110
Sponsor’s telephone number 2089831090
Plan sponsor’s address 146 W. MAIN STREET, GRANGEVILLE, ID, 835301932

Agent

Name Role Address
CHAD G JUNGERT Agent 146 W MAIN ST, GRANGEVILLE, ID 83530

President

Name Role Address Appointed On
Chad Jungert President 146 WEST MAIN STREET, GRANGEVILLE, ID 83530 2020-10-05

Filing

Filing Name Filing Number Filing date
Application for Reinstatement 0006167388 2025-03-10
Dissolution/Revocation - Administrative 0006119193 2025-02-22
Application for Reinstatement 0005641617 2024-03-08
Dissolution/Revocation - Administrative 0005620741 2024-03-01
Annual Report 0005029153 2022-12-13
Application for Reinstatement 0004620154 2022-02-22
Dissolution/Revocation - Administrative 0004617909 2022-02-19
Annual Report 0004024163 2020-10-05
Application for Reinstatement 0003780223 2020-02-12
Dissolution/Revocation - Administrative 0003773881 2020-02-06

OSHA's Inspections within Industry

Inspection Nr Report ID Date Opened Site Address
343664876 1032500 2018-12-12 146 WEST MAIN ST., GRANGEVILLE, ID, 83530
Inspection Type FollowUp
Scope Partial
Safety/Health Safety
Close Conference 2018-12-12
Case Closed 2018-12-20

Related Activity
Type Inspection
Activity Nr 1133985
Health Yes
341339851 1032500 2016-03-16 146 WEST MAIN ST., GRANGEVILLE, ID, 83530
Inspection Type Complaint
Scope Partial
Safety/Health Health
Close Conference 2016-03-18
Case Closed 2023-08-02

Related Activity
Type Complaint
Activity Nr 1070724
Safety Yes
Health Yes

Violation Items
Citation ID 01001A
Citaton Type Serious
Standard Cited 19100132 D01
Issuance Date 2016-09-01
Abatement Due Date 2016-09-28
Current Penalty 0.0
Initial Penalty 6236.0
Contest Date 2016-09-13
Final Order 2017-09-10
Nr Instances 1
Nr Exposed 3
Gravity 5
FTA Current Penalty 0.0
Citation text line 29 CFR 1910.132(d)(1): The employer did not assess the workplace to determine if hazards are present, or are likely to be present, which necessitate the use of personal protective equipment (PPE): (a) Basement compounding lab: On and before March 16, 2016, the employer did not assess the need for personal protective equipment for employees compounding and handling NIOSH listed hazardous drugs such as but not limited to estrogen, testosterone, estriol and progesterone. Note: Abatement certification is required for this item.
Citation ID 01001B
Citaton Type Serious
Standard Cited 19100133 A01
Issuance Date 2016-09-01
Abatement Due Date 2016-09-28
Current Penalty 2414.0
Initial Penalty 0.0
Contest Date 2016-09-13
Final Order 2017-09-10
Nr Instances 1
Nr Exposed 3
Gravity 5
FTA Current Penalty 0.0
Citation text line 29 CFR 1910.133(a)(1): Protective face equipment was not required where there was a reasonable probability of injury that could be prevented by such equipment: (a) Basement compounding lab: On and before March 18, 2016 employees compounding and handling NIOSH listed hazardous drugs such as but not limited to estrogen, testosterone, estriol and progesterone were not required to wear eye protection. Note Abatement certification is required for this item.
Citation ID 01002
Citaton Type Serious
Standard Cited 19100141 G02
Issuance Date 2016-09-01
Abatement Due Date 2016-09-28
Current Penalty 4828.0
Initial Penalty 6236.0
Contest Date 2016-09-13
Final Order 2017-09-10
Nr Instances 1
Nr Exposed 3
Gravity 5
FTA Current Penalty 0.0
Citation text line 29 CFR 1910.141(g)(2): Employees were permitted to consume food or beverage in area(s) exposed to toxic materials: (a) Compounding lab: On and before March 18, 2016 employees consumed beverages in the lab while compounding and handling NIOSH listed hazardous drugs such as but not limited to estrogen, testosterone and progesterone. Note: Abatement certification is required for this item.
Citation ID 01003A
Citaton Type Serious
Standard Cited 19101200 E01
Issuance Date 2016-09-01
Abatement Due Date 2016-09-28
Current Penalty 6758.0
Initial Penalty 8730.0
Contest Date 2016-09-13
Final Order 2017-09-10
Nr Instances 1
Nr Exposed 3
Gravity 10
FTA Current Penalty 0.0
Citation text line 29 CFR 1910.1200(e)(1): Employer had not developed or implemented a written hazard communication program included the requirements outlined in 29 CFR 1910.1200(e)(1)(i) and (e)(1)(ii): (a) Through out facility: On and before March 18, 2016 no written hazard communication program was established for employees required use or come in contact with hazardous compounds including but not limited to hormones, pharmaceutical ingredients, and micronized pharmaceutical agents which may have one or more of the following hazardous properties: Reproductive toxicity, mutagenic toxicity, teratogenicity, carcinogenicity, skin irritant, skin sensitizer, respiratory sensitizer, respiratory irritant, and corrosive to the eye. Note: Abatement certification and documentation is required for this item.
Citation ID 01003B
Citaton Type Serious
Standard Cited 19101200 H01
Issuance Date 2016-09-01
Abatement Due Date 2016-09-28
Current Penalty 0.0
Initial Penalty 0.0
Contest Date 2016-09-13
Final Order 2017-09-10
Nr Instances 1
Nr Exposed 3
Gravity 10
FTA Current Penalty 0.0
Citation text line 29 CFR 1910.1200(h)(1): Employees were not provided effective information and training on hazardous chemicals in their work area at the time of their initial assignment and whenever a new hazard that the employees had not been previously trained about was introduced into their work area: (a) In the compounding lab: On and before March 16, 2016 employees required to work with hazardous chemicals were not adequately trained or informed concerning the hazards of the chemicals being handled, the signs and symptoms of potential over exposure, or adequate methods of personal protection. Note: Abatement certification and documentation are required for this item.

Paycheck Protection Program

Loan Number Loan Funded Date SBA Origination Office Code Loan Delivery Method Borrower Street Address
5479047206 2020-04-27 1094 PPP 146 W MAIN ST, GRANGEVILLE, ID, 83530-1932
Loan Status Date 2021-10-19
Loan Status Paid in Full
Loan Maturity in Months 24
SBA Guaranty Percentage 100
Loan Approval Amount (at origination) 125000
Loan Approval Amount (current) 125000
Undisbursed Amount 0
Franchise Name -
Lender Location ID 59698
Servicing Lender Name Umpqua Bank
Servicing Lender Address 445 SE Main St, First Fl, ROSEBURG, OR, 97470-4934
Rural or Urban Indicator R
Hubzone Y
LMI N
Business Age Description Existing or more than 2 years old
Project Address GRANGEVILLE, IDAHO, ID, 83530-1932
Project Congressional District ID-01
Number of Employees 16
NAICS code 446110
Borrower Race Unanswered
Borrower Ethnicity Unknown/NotStated
Business Type Corporation
Originating Lender ID 59698
Originating Lender Name Umpqua Bank
Originating Lender Address ROSEBURG, OR
Gender Male Owned
Veteran Non-Veteran
Forgiveness Amount 126678.08
Forgiveness Paid Date 2021-09-08

Court Cases

Docket Number Nature of Suit Filing Date Disposition
2100161 Other Labor Litigation 2021-04-08 default
Circuit Ninth Circuit
Origin original proceeding
Jurisdiction federal question
Jury Demand Plaintiff demands jury
Demanded Amount 0
Termination Class Action Missing
Procedural Progress order decided
Nature Of Judgment monetary award only
Judgement plaintiff
Arbitration On Termination Missing
Office 3
Filing Date 2021-04-08
Termination Date 2022-01-13
Section 1331
Status Terminated

Parties
Name SECRETARY OF LABOR
Role Plaintiff
Name IRWIN DRUG, INC.
Role Defendant

Related by officers

CHAD G JUNGERT

CHAD JUNGERT AND SONS FARMS LLC

Related by address

No related companies by address

Date of last update: 31 Mar 2025

Sources: Idaho Secretary of State

Privacy policy Policy
About us About us
Contacts Contact us

© 2025 idorgs.com, Part of Big Data Integrated